Beam Therapeutics Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -72.93M-194.59M-370.64M-263.59M-132.56M-376.80M
Depreciation and Depletion 3.50M4.74M7.20M14.10M20.01M21.93M
Share-based Compensation 7.03M15.38M43.57M84.32M98.65M120.66M
Gains from Sales and Divestitures 1.64M1.02M0.42M0.47M1.30M
Gains from Investment Securities 4.79M5.34M6.03M7.55M8.28M9.61M
Non-cash Items 43.39M1.43M300.56M3.79M4.82M5.90M
Cash from Operations -72.00M-95.74M-66.27M22.53M-149.19M-347.25M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.92M-0.12M0.07M9.41M29.74M22.77M
Depreciation & Amortization (CF) 3.50M4.74M7.45M14.15M20.01M21.93M
Change in Working Capital
Change in Account Payables 4.09M0.06M0.82M2.37M-7.58M1.81M
Change in Accured Expenses 3.57M7.04M43.91M-16.93M67.66M-57.69M
Investing Activities
Capital Expenditures 12.52M16.36M46.81M48.95M33.73M8.95M
Acquisitions 0.62M
Change in Acquisitions & Divestments 76.07M198.60M529.27M1204.61M1089.91M680.39M
Cash from Investing Activities -66.66M-100.12M-294.14M-461.34M71.84M185.01M
Financing Activities
Other financing activities 2.52M2.06M8.82M0.19M0.63M
Change in Capital Stock
Shares Issued 0.18M192.51M757.45M108.26M236.57M5.60M
Preferred Shares Issued 37.90M
Misc.
Cash from Financing Activities 41.28M322.32M756.14M111.59M276.45M7.74M
Change in Cash -97.38M126.46M395.73M-327.22M199.09M-154.50M
Free Cash Flow -84.52M-112.10M-113.08M-26.42M-182.93M-356.19M
Net Cash Flow -97.38M126.46M395.73M-327.22M199.09M-154.50M